Co-design and evaluation of sensor-instrumented ‘smart socks’ (MPATIX) to improve management of distress and agitation for people with dementia

共同设计和评估传感器仪表“智能袜子”(MPATIX)，以改善痴呆症患者的痛苦和躁动管理

• 批准号: 10055596
• 金额: $ 47.66万
• 依托单位: MILBOTIX LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10055596
• 关键词: Co; design; evaluation; sensor; instrumented

More than 70% of the 430,000 care home residents in the UK have dementia or similar memory problems (Alzheimer's Society/ONS). By 2035 the UK dementia population will double to 1.6m.Dementia care is challenging and expensive, costing £35b in the UK. As communication becomes more difficult, people can struggle to request help when they are in distress. This leads to challenging behavioural symptoms (aggression, anxiety) often reflecting resolvable care issues such as discomfort/lack of pain management. Currently, around half of people with dementia experience behavioural symptoms linked to unmanaged distress.Critically, carers face challenges successfully meeting the needs of people with dementia who cannot identify or communicate why/that they are in distress. There is an unmet need for technological solutions which support carers to promptly respond to individuals' unique needs and situational triggers.Milbotix have developed MPATIX Smart Socks, which incorporate sensors that track pulse, sweat, temperature and motion to give accurate insights on the wearer's wellbeing. Utilising our novel machine learning algorithm and mobile application, we can provide unique anxiety/distress information, without disruption for people with dementia or their carers. Looking and feeling like normal socks, the MPATIX socks are machine washable and don't require charging. MPATIX integrates with care home data systems allowing the system to augment existing workflows for easier adoption.Funded by Alzheimer's Society, the UK's leading dementia charity, Milbotix has developed a validated TRL 6 prototype, which has demonstrated reliability at detecting anxiety (74%-98% accurate). This project will develop a trial-ready version, enabling the necessary large-scale RCT which fully quantifies and demonstrates the care provider and individual benefits of deployment.With MPATIX, we are ideally positioned to address a rapidly growing market opportunity and emerging social challenge in an ageing population.

在英国43万名养老院居民中，超过70%的人患有痴呆症或类似的记忆问题(阿尔茨海默氏症协会/英国国家统计局)。到2035年，英国痴呆症人口将翻一番，达到160万。痴呆症治疗具有挑战性，而且成本高昂，在英国需要花费350亿英镑。随着沟通变得越来越困难，人们在遇到困难时可能很难请求帮助。这导致具有挑战性的行为症状(攻击性、焦虑症)，通常反映出可解决的护理问题，如不适/缺乏疼痛管理。目前，约有一半的痴呆症患者出现与无法控制的痛苦有关的行为症状。关键是，照顾者面临着成功满足痴呆症患者的需求的挑战，这些人无法确定或沟通他们陷入痛苦的原因/。对支持护理者迅速响应个人独特需求和情景触发的技术解决方案的需求尚未得到满足。Milbotix开发了MPATIX智能袜子，其中包含跟踪脉搏、汗水、温度和运动的传感器，以准确了解穿着者的健康状况。利用我们新颖的机器学习算法和移动应用程序，我们可以为痴呆症患者或他们的照顾者提供独特的焦虑/痛苦信息，而不会中断。MPATIX袜子看起来和摸起来都像普通袜子，可以机洗，不需要充电。MPATIX与疗养院数据系统集成，使该系统能够增强现有的工作流程，使之更容易采用。在英国领先的痴呆症慈善机构阿尔茨海默病协会的资助下，Milbotix开发了一种经过验证的TRL 6原型，该原型已证明在检测焦虑方面的可靠性(74%-98%)。该项目将开发一个试用版本，实现必要的大规模随机对照试验，充分量化和展示护理提供者和个人部署的好处。通过MPATIX，我们处于理想地位，以应对人口老龄化中快速增长的市场机会和新出现的社会挑战。